Profile data is unavailable for this security.
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, independent delivery networks (IDNs), health plans, employers, consumers, and accountable care organizations (ACOs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provide insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology business, which offers solutions for healthcare providers. The Company’s services are primarily provided under the Quest Diagnostics brand and also provide services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
- Revenue in USD (TTM)9.60bn
- Net income in USD789.00m
- LocationQuest Diagnostics Inc500 Plaza DriveSECAUCUS 07094United StatesUSA
- Phone+1 (973) 520-2700
- Fax+1 (302) 655-5049
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|DGX:NYQ since |
|Haystack Oncology Inc||Announced||27 Apr 2023||27 Apr 2023Announced||-8.90%||450.00m|
|Newyork-Presbyterian Hospital-Laboratory Services Business||Deal completed||14 Feb 2023||14 Feb 2023Deal completed||-8.55%||--|
|Northern Light Laboratory||Deal completed||08 Dec 2022||08 Dec 2022Deal completed||-10.22%||--|
|LabCare PLUS||Announced||05 Oct 2022||05 Oct 2022Announced||4.43%||--|